Scientists demonstrate that AI-risk models, paired with AI-designed screening policies, can offer significant and equitable improvements to cancer screening.
To help clinicians avoid remedies that may potentially contribute to a patient’s death, researchers at MIT and elsewhere have developed a machine-learning model that could be used to identify treatments that pose a higher risk than other options.